Trial intelligence / Profile preview

INCED: Cefepime PK in ICU Patients

NCT02680600Completed

Sponsor
OLV Hospital
Start
Mar 2014
Primary completion
Jul 2015
Modality
Reversible Covalent Inhibitors
01

Overview

Open-label, single-arm trial of cefepime in sepsis, pneumonia and bacterial infection, sponsored by OLV Hospital. Primary endpoints: Median absolute predictive error of population PK model without covariates at 5 days and Median absolute predictive error of population PK model with different renal markers incorporated at 5 days. Started Mar 2014; status: completed.

02

Drugs

cefepime
03

Conditions

sepsispneumoniabacterial infection

Beyond the preview

Go deeper on NCT02680600.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02680600.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call